Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.04
Delayed Data
As of Feb 17
 +0.035 / +0.29%
Today’s Change
8.67
Today|||52-Week Range
14.15
+12.52%
Year-to-Date

Today’s Trading

Previous close12.01
Today’s open11.97
Day’s range11.82 - 12.09
Volume646,899
Average volume (3 months)931,129
Market cap$1.3B
Dividend yield8.31%
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+142.77%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+97.09%
P/E ratio34.4
Price/Sales9.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.10-0.38%
EBSEmergent BioSolution...-0.54-1.75%
FWPForward Pharma A/S+0.09+0.30%
DERMDermira Inc+0.60+1.81%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$133.6M
Annual profit (last year)$59.5M
Net profit margin44.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs